Taha GÜRSOY

Dr. Taha GÜRSOY

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2022 in Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Verified
Journal Article
Closed access
BKBayram Kudret Karaayvaz
Bayram Kudret Karaayvaz
RKReyda Kiyici
Reyda Kiyici
YÖYahya Öztürk
Yahya Öztürk
IBİbrahim Bağci
İbrahim Bağci
TGTaha GÜRSOY
Taha GÜRSOY
MKMehmet Karaca
Mehmet Karaca
Leptin is a hormone that provides the central and/or peripheral regulation of food intake, energy expenditure, whole body energy balance, fertility and immune functions by creating a feeling of satiety in animals and humans. This study was carried out to determine serum leptin values for some ruminant species and breeds that were healthy and had at least one birth. In the study, 15 Simental and 15 Holstein cows, 15 Italian buffalo, 15 Pırlak sheep, 15 Honamlı and 15 Turkish hair goats were used as material. Serum leptin concentrations were measured with the BT LAB Bovine Leptin ELISA kit. Serum leptin levels were determined as 2.78±0.22 ng/ml in Simmental cows, 2.87±0.11 ng/ml in Holstein cows, 3.6±0.48 ng/ml in Pırlak sheep, 3.38±0.76 ng/ml in Honamlı goats, 5.48±0.92 ng/ml in Hair goats and 2.50±0.17 ng/ml in Italian buffaloes. As a result, it was determined that serum leptin levels obtained from different ruminant species that were healthy and gave at least one birth in Burdur province were within the reference values reported for ruminants.

31 August 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
ZİZiya İlhan
Ziya İlhan
RŞReyda Şıklaroğlu
Reyda Şıklaroğlu
MGMurad Gürses
Murad Gürses
MBMurat Bayezit
Murat Bayezit
TGTaha GÜRSOY
Taha GÜRSOY
HAHasan Altan AKKAN
Hasan Altan AKKAN
Background/Objectives: The increasing prevalence of antimicrobial resistance has reduced the effectiveness of conventional antibiotics, highlighting the need for alternative or adjunct antimicrobial agents. This study aimed to investigate the antibacterial, synergistic, and antibiofilm activities of Liquidambar orientalis Mill. essential oil against clinically relevant bacterial pathogens, using 24 bacterial strains representing 12 bacterial species. Methods: The volatile constituents of L. orientalis essential oil obtained by hydrodistillation of storax balsam were characterized by gas chromatography-mass spectrometry (GC-MS) and gas chromatography-flame ionization detection (GC-FID). Antibacterial activity was evaluated using minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), disk diffusion, and agar well diffusion assays against a panel of Gram-positive and Gram-negative bacterial pathogens. Synergistic interactions with erythromycin, amoxicillin, gentamicin, and enrofloxacin were assessed using fractional inhibitory concentration index (FICI) analysis. Antibiofilm activity was also evaluated against representative biofilm-forming strains. Results: A total of 90 volatile constituents were identified by GC-MS, of which styrene was the most abundant (68.6%), followed by (E)-ethyl cinnamate (6.8%), α-pinene (5.9%), and β-pinene (2.9%). The essential oil exhibited broad-spectrum antibacterial activity, with an overall inhibition rate of 60.4%. Activity was higher against Gram-positive (77.77%) than Gram-negative (73.33%) bacteria. MIC and MBC values ranged from 15.62 to 250 µg/mL and 31.25 to 250 µg/mL, respectively. FICI analysis revealed strain- and antibiotic-dependent interactions, ranging from synergistic to antagonistic effects. Variable antibiofilm activity was observed, with the strongest inhibition against Brucella melitensis and the weakest against Pseudomonas aeruginosa. No significant differences in MIC or MBC values were observed between bacterial groups (p > 0.05). Conclusions: L. orientalis essential oil demonstrated in vitro antibacterial activity against several clinically relevant pathogens, with particularly notable activity against B. melitensis. The essential oil also showed synergistic interactions with selected antibiotics and variable antibiofilm effects. These findings suggest that L. orientalis essential oil may have potential as an antibacterial agent or adjunct to antibiotic therapy; however, further in vivo and clinical studies are required to confirm its therapeutic applicability.

20 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
RŞReyda Şıklaroğlu
Reyda Şıklaroğlu
TGTaha GÜRSOY
Taha GÜRSOY
YMYavuz MUSABEŞEOĞLU
Yavuz MUSABEŞEOĞLU
MKMEHMET Karaca
MEHMET Karaca
YMYavuz Musabeşeoğlu
Yavuz Musabeşeoğlu
HAHasan Altan AKKAN
Hasan Altan AKKAN
In this study, it was aimed to deterimine the in vitro antibacterial activity of Anatolian Sweetgum (Liquidambar orientalis Mill.) oil (ASO) against Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Listeria monocytogenes, Salmonella typhimurium, Pseudomonas aeruginosa, Mannheimia haemolytica, Brucella melitensis, and Corynebacterium pseudotoberculosis strains. Methods: The volatile constituents of ASO were determined by gas chromatograph/mass selective detector (GC/MSD) system. The amount of α-pinene, camphene, benzaldehyde, sabinene, p-cymene, dl-limonene, benzyl alcohol, 3-phenyl-1-propanol, cinnamaldehyde, cinnamyl alcohol, ethyl cinnamate, geraniol acetate, torreyol, benzyl cinnamate, 3-methyl-3-phenyl-azetidin, 4-methylcoumarine-7-cinnamate, acetyl tributyl citrate, (1-methylcyclobutyl) benzene, cinnamyl cinnamate, squalene, and other compounds were determined. Disc diffusion and agar well diffusion tests were used to determine the in vitro antibacterial activity of ASO. Results: The volatile constituents of ASO were found in amounts ranging from 0.01% (camphene) to 62.56% (cinnamyl cinnamate). ASO showed in vitro antibacterial activity against tested bacterial strains as 58.3% and 62.5% by the disk diffusion test and agar well diffusion test, respectively. The antibacterial activity of ASO was determined to be slightly higher in Gram-positive bacteria (80.0%) than in Gram-negative bacteria (78.57%). The highest antibacterial activity was detected against S. aureus by the disk diffusion test and against B. melitensis by the agar well diffusion test. Conclusions: The results highlight the potential of ASO as an antibacterial activity against a broad spectrum of bacterial strains, with slightly higher efficacy against Gram-positive bacteria. To confirm these findings and explore practical applications, additional in vivo studies are required to evaluate its therapeutic applicability in combating bacterial infections in both human and veterinary medicine.

8 October 2026 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
TGTaha GÜRSOY
Taha GÜRSOY
YÇYunus Çetin
Yunus Çetin
Background: Micronutrients involved in antioxidant defense may influence ovarian function and embryo competence, but evidence regarding combined vitamin–mineral rumen boluses administered before superovulation is limited. This randomized exploratory trial evaluated whether a single rumen bolus containing vitamin A, beta-carotene, vitamin E, zinc, and selenium, administered 21 days before superovulation, altered circulating micronutrient concentrations, ovarian response, and embryo outcomes. Twenty-two clinically healthy primiparous Holstein donor cows were allocated to bolus ( n = 11) or untreated control ( n = 11) groups across two experimental periods. All donors underwent the same synchronization, superovulation, artificial insemination, and embryo-recovery protocol. Blood was collected at baseline and on the day of embryo recovery, and embryo morphology was assessed by an evaluator unaware of group allocation. Results: The bolus and control groups yielded 115 and 86 recovered structures, respectively, of which 103 and 65 were transferable. After adjustment for experimental period, however, neither total recovered structures (incidence rate ratio [IRR], 1.34; 95% confidence interval [CI], 0.91–1.92; P = 0.211; false-discovery-rate-adjusted P [q] = 0.685) nor transferable embryos (IRR, 1.56; 95% CI, 0.97–2.45; P = 0.127; q = 0.685) differed significantly between groups. The adjusted difference in donor-level transferable-embryo proportion was 12.7 percentage points (95% CI, − 5.2 to 32.3; P = 0.294; q = 0.685). Follicle, ovulation, corpus luteum, and non-transferable embryo counts also showed no statistically supported differences. No measured blood analyte showed a differential change between groups; all 95% CIs for fold-change ratios included 1 ( P ≥ 0.394; q = 0.853). Sensitivity analyses did not alter these interpretations. Conclusions: Under the conditions of this exploratory study, bolus administration did not result in statistically supported improvements in circulating micronutrient status, ovarian response, or embryo outcomes. Although point estimates for total and transferable embryo counts favored the bolus group, the small sample and wide confidence intervals preclude firm conclusions about benefit or lack of benefit. Routine use solely to enhance superovulation outcomes is therefore not supported by these data. Larger, adequately powered trials incorporating dietary micronutrient characterization, verified bolus-release kinetics, and control of semen-source effects are warranted.

6 October 2026 in Animal Health Production and Hygiene
Verified
Journal Article
Open access
TGTaha GÜRSOY
Taha GÜRSOY
ÖAÖmer Aykul
Ömer Aykul
This retrospective, single-herd, record-based study assessed the availability and interpretability of quarter-level organism and treatment records from a university dairy herd. Seventeen documented mastitis episodes from 14 cows (1 August 2025–9 July 2026) included 36 quarter fields with organism entries. Escherichia coli, Streptococcus spp., coagulase-negative staphylococci, and Streptococcus uberis were recorded in 11/36 (30.6%), 9/36 (25.0%), 9/36 (25.0%), and 7/36 (19.4%) fields, respectively; 9/36 (25.0%) contained multiple categories. Ceftiofur and flunixin meglumine were documented in 12/17 (70.6%) and 11/17 (64.7%) episodes. Standardized severity, laboratory metadata, linked susceptibility findings, complete treatment regimens, and outcomes were unavailable or incompletely reconstructable. The records therefore supported descriptive reconstruction but not epidemiological estimates, microbiological validation, treatment-effectiveness assessment, or recurrence classification. Unique case-to-laboratory linkage is required for stronger retrospective inference.

30 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
RŞReyda Şıklaroğlu
Reyda Şıklaroğlu
ZİZiya İlhan
Ziya İlhan
MGMurad GÜRSES
Murad GÜRSES
MBMurat Bayezit
Murat Bayezit
TGTaha GÜRSOY
Taha GÜRSOY
HAHasan Altan AKKAN
Hasan Altan AKKAN
Background: Antibiotic resistance is one of the most critical challenges in treating bacterial infections today. The widespread and often inappropriate use of antibiotics has accelerated the emergence of resistant bacterial strains, making many conventional therapies ineffective. Without effective strategies to address this growing issue, bacterial pandemics that pose severe threats to global public health could emerge in the future. Objectives: This aim of this study was to investigate in vitro antibacterial activity of Liquidambar orientalis Mill. essential oil against strains of Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, E. faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Listeria monocytogenes, Salmonella Typhimurium, Pseudomonas aeruginosa, Mannheimia haemolytica, Brucella melitensis, and Corynebacterium pseudotuberculosis. Methods: The volatile constituents of L. orientalis Mill. essential oil were analyzed by gas chromatography–mass spectrometry (GC-MS), and its antibacterial activity was assessed using disc diffusion and agar well diffusion methods. The McNemar test was used to statistically evaluate the difference in the detection rates of resistance/sensitivity between disc diffusion test and well diffusion test results. Results: GC-MS analysis identified 21 chemical constituents in L. orientalis Mill. essential oil, with cinnamyl cinnamate (62.56%), (1-methylcyclobutyl) benzene (31.30%), and squalene (2.96%) as the major components. Minor constituents such as α-pinene, camphene, benzaldehyde, and benzyl alcohol were detected at concentrations below 1%. The essential oil demonstrated in vitro antibacterial activity against the tested bacterial strains, with inhibition rates of 58.3% and 62.5% in the disc diffusion and agar well diffusion tests, respectively. Antibacterial activity was slightly higher against Gram-positive bacteria (80.0%) compared to Gram-negative strains (78.57%). The highest activity was observed against S. aureus in the disc diffusion test and against B. melitensis in the agar well diffusion test. No statistically significant difference was observed between the two methods regarding resistant/sensitive detection rates. Conclusions: L. orientalis Mill. essential oil exhibited strong in vitro antibacterial activity against S. aureus, B. melitensis, E. coli, E. faecium, K. pneumoniae, and M. hemolytica, particularly at concentrations of 62.5, 31.25, and 15.62 µg/ml. These results suggest its potential as a broad-spectrum antibacterial agent. Notably, when combined with antibiotics, it may offer therapeutic advantages against B. melitensis, the primary causative agent of human brucellosis. However, further in vivo studies are required to validate these findings and assess its practical applications in treating bacterial infections in both human and veterinary medicine.